Recent Updates
Recently added Catalysts
ABBV Positive Sentiment

AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference

Monday, August 31, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: AbbVie will participate in the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026. The management will engage in a fireside chat at 9:15 a.m. Central time, with a live audio webcast available on their Investor Relations website. An archived version will also be accessible later that day.

Market Sentiment Analysis

POSITIVE FACTORS

  • AbbVie is actively engaging with investors at a major healthcare conference.
  • The company is committed to addressing serious health issues through innovative solutions.
  • A live audio webcast will allow broader access to the presentation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+33%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Paricalcitol
Phase 3 · Chronic Kidney Disease Stage 3 and 4

Full Press Release Details

NORTH CHICAGO, Ill., Aug. 31, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026. Management will participate in a fireside chat at 9:15 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Catherine Langel (708) 508-3524 [email protected] Investors: Liz Shea (847) 935-2211 [email protected]

Investors:

Liz Shea (847) 935-2211
[email protected]

Frequently Asked Questions

When is AbbVie's presentation at the conference?

AbbVie's presentation is scheduled for September 9, 2026.

How can I access the presentation?

The presentation will be available via a live audio webcast on AbbVie's Investor Relations website.

What time does AbbVie's fireside chat start?

The fireside chat will begin at 9:15 a.m. Central time.

Will there be a recording of the session?

Yes, an archived edition of the session will be available later that day.

ShareAdd on Google
Tags: ABBV Viatris Investor Conferences Healthcare AbbVie Wells Fargo Healthcare Conference Investor Relations biopharma
Last updated: Aug 31, 2026

Biotech snapshot

Cash runway
$6569M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ParicalcitolPhase 3
Chronic Kidney Disease Stage 3 and 4 →

Catalyst track record

+33%
best trade around ABBV's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for ABBV.

See every catalyst's timing & PoA →